Muscle Tissue Fluid Testing for Rapid Post-Mortem Drug Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for post-mortem forensic drug analysis are time-consuming and inefficient, particularly in cases of extensive decomposition, and lack sensitivity in detecting and quantifying non-naturally occurring drugs using traditional biological matrices like blood, urine, and liver tissue.
Innovation Solution
A rapid method using muscle tissue and associated fluids for forensic drug testing, employing Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) to detect and quantify non-naturally occurring drugs, providing results in as little as three hours.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional biological matrices (blood, urine, liver tissue) are used for post-mortem drug analysis, then the analysis can be conducted using established methods, but the process is time-consuming and samples may become unsuitable for analysis due to decomposition and pH changes
Solution Approach 1:
The patent changes the biological matrix parameter from traditional fluids (blood, urine) to muscle tissue, which maintains structural integrity and drug concentration stability post-mortem. This parameter change allows samples to remain suitable for analysis even after death, eliminating the time constraint while maintaining reliability
Solution Approach 2:
The method performs drug analysis on muscle tissue that can be collected and stored without immediate analysis, as the tissue maintains stability. This preliminary collection and stabilization of the sample allows for later analysis without degradation, effectively preparing the sample in advance for reliable results
2Ease of operation
If traditional biological matrices are used, then sample collection is straightforward, but drug concentration variability is high due to clotting time, fluid movement, and cellular component changes
Solution Approach 1:
Changing the matrix from fluid-based samples (blood, urine) to solid muscle tissue eliminates the harmful effects of clotting, fluid movement, and cellular degradation. Muscle tissue provides a stable, consistent matrix that maintains uniform drug concentrations, improving measurement precision while remaining easy to collect
Solution Approach 2:
The method uses muscle tissue that can be easily obtained during autopsy and does not require special preservation or immediate processing like traditional fluids. The tissue serves as a disposable, stable sample source that maintains integrity without complex handling procedures
3Reliability
If extensive decomposition has occurred, then traditional sample matrices are hard to retrieve and limited to putrefactive fluids, but the patent achieves successful drug detection and quantification
Solution Approach 1:
The patent changes the sample matrix from decomposing fluids to muscle tissue, which retains structural integrity even in extensively decomposed remains. This parameter change ensures sample availability in cases where traditional matrices would be unavailable, eliminating retrieval difficulty while maintaining reliability
Solution Approach 2:
The method converts the harmful effect of decomposition, which destroys traditional fluid matrices, into a benefit by using muscle tissue that actually preserves drug concentrations better during decomposition. The decomposed state that destroys blood and urine actually highlights the superior stability of muscle tissue as a sample source
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves faster and more sensitive detection and quantification of non-naturally occurring drugs in post-mortem individuals compared to traditional methods, with results obtained within three hours.
Implementation Method 1
analyzing the sample of muscle tissue fluid using a Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) method to detect and quantify the one or more non-naturally occurring drugs
Implementation Method 2
analyzing the sample of muscle tissue fluid using a Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) method to detect and quantify the one or more non-naturally occurring drugs
Data Source
AI summary
The present invention provides a rapid method for forensic drug testing in a post-mortem individual using muscle tissue and fluid associated with the muscle tissue obtained from remains of the post-mortem individual. The method comprises obtaining muscle tissue and associated fluid from a post-mortem individual, collecting the fluid associated with the muscle tissue, analyzing the fluid associated with the muscle tissue to detect and quantify one or more non-naturally occurring drugs in the post-mortem individual, and identifying the one or more non-naturally occurring drugs in the post-mortem individual. The detection and quantification of non-naturally occurring drugs in muscle tissue and associated fluid is surprisingly faster than detection and quantification of the non-naturally occurring drugs in muscle tissue obtained from the same post-mortem individual and prepared as muscle tissue homogenates using the LC-MS/MS method, with results obtained in as soon as three hours.